Navigation Links
Caliper Life Sciences Reports First Quarter 2008 Results
Date:5/8/2008

8,930

License fees and contract revenue 2,614 4,249

Total revenue 29,287 28,440

Costs and expenses:

Cost of product revenue 11,105 9,967

Cost of service revenue 6,098 5,653

Cost of license revenue 284 442

Research and development 5,532 6,774

Selling, general and administrative 13,932 12,607

Amortization of intangible assets 2,490 2,537

Restructuring charges, net 6 26

Total costs and expenses 39,447 38,006

Operating loss (10,160) (9,566)

Interest income, net (155) 7

Other income, net 407 13

Provision for income taxes (28) (51)

Net loss $(9,936) $(9,597)

Net loss per share, basic and diluted $(0.21) $(0.20)

Shares used in computing net loss per common

share, basic and diluted 47,683 46,979

Reconciliation of GAAP to Non-GAAP Financial Measure

Adjusted Earnings per Share (see explanation of adjustments below)

Three Months Ended

March 31,

2008 2007

GAAP EPS $(0.21) $(0.20)

Adjustments:

Share-based compensation expense (1) 1,010
'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results
2. Caliper Life Sciences Ships 500th IVIS Imaging System
3. Derma Sciences Announces Date of Its First Quarter 2008 Earnings Release and Conference Call on May 15, 2008
4. Applied Precision Announces Sale of Life Sciences Business Unit to Senior Management and Telegraph Hill Partners
5. Argonnes Crabtree Elected to National Academy of Sciences
6. 2 NYU faculty elected to National Academy of Sciences
7. Derma Sciences Receives Third FDA Clearance for MEDIHONEY(TM) Wound & Burn Dressings
8. Arkion(R) Life Sciences Receives Crisis Exemption to US EPA Section 18 Approval in Mississippi and Tennessee to Market Avitec Corn Seed Treatment
9. Microsoft Health & Life Sciences Developer and Solutions Conference to Feature the Latest Microsoft-Based Software Solutions
10. Life Sciences Fund grants awards to launch health research
11. Life Sciences Discovery Fund Awards $2.2 Million to Support New Solid-Tumor Research Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...PRNewswire-USNewswire/ -- A regional initiative la...iver blindness) in the Americas has substantially ...ars, as evidenced by a 31% decrease in the number ...in six endemic countries. Results were reported t...ciety of Tropical Medicine and Hygiene (ASTMH). ,...
(Date:11/21/2009)...ve medical apparel company launches men,s lab coat... San Clemente, Calif. (PRWEB) November 21, 200...apparel, today announced the launch of its men,s l...eading international trade fair for the medical in...urates its men,s collection with three varying lab...
(Date:11/21/2009)...Group ask whether there is a secret to ,alcohol re... London, UK (PRWEB) November 21, 2009...ree of the adult UK population drinking enough alc...d liver disease*, it is hardly a surprise that man...ammes and residential centres for help. However, f...
(Date:11/20/2009)...0 The United States Con...ke essential changes its health reform bill in ord...g and conscience protection on abortion, protect a...rong provisions for adequate affordability. ,, ..."enormous disappointment" that creates new and una...
(Date:11/20/2009)...swire-USNewswire/ -- The American Dental Associati...stration (FDA) to establish appropriate classifica... concern about the safety of whitening products th...rofessional consultation or examination by a denti...hemically based tooth whitening or bleaching agent...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
...ANNAH, Ga., Feb. 13 Founders Club will donate $5 ... Mammography Fund at St. Joseph,s/Candler. , , ...mmunity. Early detection is crucial in the fight a...lty golf retail stores across the United States. ,...
...al associate health coverage increases to more tha...-Mart Stores, Inc., (NYSE: WMT ) announced today...e coverage through its benefits plans for 2009 or ...endants in total - were covered by Wal-Mart,s plan...
...l Sense(TM) Device completes successful clinical e...nel Group announced the completion of the first st...onducted at Galenia Hospital in Cancun, Mexico by ...or 6 weeks to evaluate weight loss, satiety (lack ...
...t says the dark kind protects against cancer, alon...althDay News) -- Giving dark chocolate to your Val...rd your true love against cancer. , "The great new...Sally Scroggs, a health education manager at the U...
... HONG KONG, Feb. 13 /PRNewswire-Asia-FirstCall/ --...lthcare services provider, Golden Meditech,Company...8180) is pleased to,announce today the third quart...crease of 25% on a year-on-year basis. , Durin...
... BIRMINGHAM, Ala., Feb. 13 Emageon Inc. (Nasdaq:,...on technology systems for,hospitals and health car...he,$9 million that had been placed in escrow with ...owed funds became payable to Emageon,when the merg...
Other Medicine News:Health News:Founders Club Proudly Supports the St. Joseph's/Candler Mammography Fund 2Health News:Wal-Mart Health Care Benefits Enrollment Rises, Uninsured Rate Declines 2Health News:Wal-Mart Health Care Benefits Enrollment Rises, Uninsured Rate Declines 3Health News:Weight Loss Without Hunger! 2Health News:Chocolate for Your Valentine a Healthy Idea 2Health News:Golden Meditech Releases FY2008/09 Q3 Results 2Health News:Golden Meditech Releases FY2008/09 Q3 Results 3Health News:Emageon Receives Escrowed Funds and Terminates Merger Agreement 2Health News:Emageon Receives Escrowed Funds and Terminates Merger Agreement 3
(Date:11/20/2009)...LIN LAKES, N.J., Nov. 20 ... today announced the completion of its acquisition...ompany that develops and manufactures molecular di... May 2009, BD and HandyLab announced an exclusive ...cular assays on the HandyLab Jaguar(TM) platform, ...
(Date:11/19/2009)... France, Nov. 19 In response to an...erous and illegal medicines, Operation Pangea II, ...L and the World Health Organization,s Internationa...IMPACT) to highlight the dangers of buying medicin...esulted in a series of arrests and the seizure of ...
(Date:11/19/2009)...TT PARK, Ill., Nov. 19 ...BT ) as one of its Most Admired Corporate Dealmake...nored Abbott as its Most Admired Dealmaker in phar... acquisitions and divestitures since January 2006....ts business portfolio with a focus on high-growth,...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3PEAK Surgical Announces Results of First PRECISE Studies at American College of Surgeons Clinical Congress 5492 1PEAK Surgical Announces Results of First PRECISE Studies at American College of Surgeons Clinical Congress 5492 2PEAK Surgical Announces Results of First PRECISE Studies at American College of Surgeons Clinical Congress 5492 3At Waters Forum Rep DeLauro Administration Urge Congress to Improve the Safety of Imported Food 59483 1At Waters Forum Rep DeLauro Administration Urge Congress to Improve the Safety of Imported Food 59483 2At Waters Forum Rep DeLauro Administration Urge Congress to Improve the Safety of Imported Food 59483 3Quicker Referral for Gallbladder Operation Could Save 50 Percent of Preoperative Treatment Charges 59481 1Quicker Referral for Gallbladder Operation Could Save 50 Percent of Preoperative Treatment Charges 59481 2Quicker Referral for Gallbladder Operation Could Save 50 Percent of Preoperative Treatment Charges 59481 3
...E, Conn., Dec. 7 /PRNewswire-FirstCall/-- Soliris(...veloped by Alexion Pharmaceuticals, Inc.,(Nasdaq: ... hemoglobinuria (PNH),was associated with an impro...er of patients with two other rare and severe comp...ical trial, according to patient cases presented,t...
..., Dec. 6 Phase III data on carisbamate, an,invest... the adjunctive,treatment of partial onset seizure... presented today during the poster sessions of the...ety. , Results from two identical placebo-co...y, safety and tolerability of carisbamate as an,ad...
Other Medicine Technology:First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting 2First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting 3First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting 4First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting 5First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting 6Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 2Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 3Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 4Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 5
DCR Set - Angled
IOL Manipulator - Sinskey
J Cortex Extrator - Angled Left
Cortex Extractor
Medicine Products: